Additional information
Yellow Powder
151110-15-5
ACI-020806
191.6-194.8°C
C11H8BrN5
290.12
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
5-Bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine
5-Bromo-N-1H-imidazol-2-yl-6-quinoxalinamine
4,5-Didehydro Brimonidine





![DESACETYL PALBOCICLIB HYDROCHLORIDE (25 mg) (8-Cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride (1:1))](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)